These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM. Koganei S, Ito M, Yamamoto K, Matsumoto N. Immunol Lett; 2005 May 15; 98(2):232-44. PubMed ID: 15860223 [Abstract] [Full Text] [Related]
8. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants. Starnes CO, Carroll WL, Campbell MJ, Houston LL, Apell G, Levy R. J Immunol; 1988 Jul 01; 141(1):333-9. PubMed ID: 3132505 [Abstract] [Full Text] [Related]
9. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas. Giardina SL, Schroff RW, Kipps TJ, Woodhouse CS, Abrams PG, Rager HC, Morgan AC, Foon KA. J Immunol; 1985 Jul 01; 135(1):653-8. PubMed ID: 3873497 [Abstract] [Full Text] [Related]
10. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. Hatzubai A, Maloney DG, Levy R. J Immunol; 1981 Jun 01; 126(6):2397-402. PubMed ID: 6785351 [Abstract] [Full Text] [Related]
11. Monoclonal antibodies to murine leukemia virus gp 70 recognize the same T lymphoma cell surface molecules as anti-immunoglobulin. Baird S, Lesley J, Majda J, Raschke W. J Immunol; 1983 Sep 01; 131(3):1576-81. PubMed ID: 6604102 [Abstract] [Full Text] [Related]
12. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules. UytdeHaag F, Claassen I, Bunschoten H, Loggen H, Ottenhoff T, Teeuwsen V, Osterhaus A. J Mol Cell Immunol; 1987 Sep 01; 3(3):145-55. PubMed ID: 2908179 [Abstract] [Full Text] [Related]
13. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM. Qian GX, Fu SM, Solanki DL, Rai KR. J Immunol; 1984 Dec 01; 133(6):3396-400. PubMed ID: 6333459 [Abstract] [Full Text] [Related]
14. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma. Weiner GJ, Kaminski MS. J Immunol; 1989 Jan 01; 142(1):343-51. PubMed ID: 2783325 [Abstract] [Full Text] [Related]
17. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V, Kumar L, Subbarao B. J Immunol; 1991 Jun 15; 146(12):4120-9. PubMed ID: 2040794 [Abstract] [Full Text] [Related]
18. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones. Rudensky AY, Mazel SM, Blechman JM, Yurin VL. Eur J Immunol; 1990 Aug 15; 20(8):1691-6. PubMed ID: 2120062 [Abstract] [Full Text] [Related]
19. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. Meeker T, Lowder J, Cleary ML, Stewart S, Warnke R, Sklar J, Levy R. N Engl J Med; 1985 Jun 27; 312(26):1658-65. PubMed ID: 3923352 [Abstract] [Full Text] [Related]
20. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M, Ria F, Parrella P, Signori E, Serra A, Ciafrè SA, Vespignani I, Lazzari M, Farace MG, Saglio G, Fazio VM. Cancer Res; 2001 Feb 15; 61(4):1555-62. PubMed ID: 11245465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]